Palleon Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics for autoimmunity and cancer, ...

An estimated 1 in 15 Americans lives with an autoimmune disease, yet the average patient sees six doctors over four years ...

CRISPR Therapeutics (Nasdaq: CRSP), today announced that a poster presentation highlighting the Company’s Phase 1 clinical ...

For people living with autoimmune connective tissue diseases, the question of whether to have children is rarely a simple one ...

Bio has launched with $48 million in Series A funding to develop therapies designed to directly target and eliminate ...

Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing ...

There are more than 100 autoimmune diseases. Here’s how they’re diagnosed.

Our immune system has a dark side: It's supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

Autoimmune diseases now affect a substantial and growing share of the global population, and yet most current therapies blunt the immune system broadly rather than correcting the specific molecular ...

Researchers have long known that women are more likely to develop autoimmune disorders than men, though they’ve struggled to fully understand why. Now a new study in mice suggests a key part of the ...

ROI strategy: prioritize CD19 and neuroimmunology, anchor trials in Germany and the UK, and back allogeneic/in vivo platforms to cut costs and ease market access.Dublin, Oct. 02, 2026 (GLOBE NEWSWIRE) ...